Table of Contents

company-logo

ABIVAX Société Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. Its principal products include ABX464 that is in Phase IIb clinical trials for the treatment of ulcerative colitis and Crohn's Disease, as well as for COVID-19; Phase IIa clinical trial for the treatment of rheumatoid arthritis diseases; and has completed Phase IIa clinical trial for the treatment of viral remission in patients with HIV. It also develops ABX 196, an immune enhancer candidate that is in Phase 1/2 clinical trials for the treatment of hepatocellular cancer. In addition, the company engages in the research programs for the treatment of Dengue fever, influenza, and respiratory syncytial virus. ABIVAX Société Anonyme has license contracts with the French National Centre for Scientific Research, the University of Montpellier, and the Institut Curie. The company was incorporated in 2013 and is headquartered in Paris, France.

ABIVAX Dividend Announcement

• ABIVAX does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on ABIVAX dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

ABIVAX Dividend History

ABIVAX Dividend Yield

ABIVAX current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing ABIVAX stock? Use our calculator to estimate your expected dividend yield:

ABIVAX Financial Ratios

P/E ratio-3.68
PEG ratio1.08
P/B ratio5.16
ROE-110.04%
Payout ratio0.00%
Current ratio3.04
Quick ratio3.04
Cash Ratio2.78

ABIVAX Dividend FAQ

Does ABIVAX stock pay dividends?
ABIVAX does not currently pay dividends to its shareholders.
Has ABIVAX ever paid a dividend?
No, ABIVAX has no a history of paying dividends to its shareholders. ABIVAX is not known for its dividend payments.
Why doesn't ABIVAX pay dividends?
There are several potential reasons why ABIVAX would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will ABIVAX ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While ABIVAX has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is ABIVAX a dividend aristocrat?
ABIVAX is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is ABIVAX a dividend king?
ABIVAX is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is ABIVAX a dividend stock?
No, ABIVAX is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy ABIVAX stocks?
To buy ABIVAX you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy ABIVAX stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.